Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.
Urica Therapeutics has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in January 2023.
Urica Therapeutics is headquartered in Miami, United States.
Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.
Urica Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Urica Therapeutics — Funding & Investors." VCBacked, January 5, 2023, https://www.vcbacked.co/company/urica-therapeutics. Accessed August 14, 2026.
VCBacked. (2023). Urica Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/urica-therapeutics
{{cite web |title=Urica Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/urica-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated